CSIMarket
 
Absci Corp  (ABSI)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Absci Corp

Business Description


Absci Corp is a biotechnology company located in the United States that specializes in designing and developing novel therapeutic proteins. The company was founded in 2011 by Sean McClain, who serves as its CEO. Absci Corp is headquartered in Vancouver, Washington, and has a state-of-the-art research facility that spans over 25,000 square feet.

The primary focus of Absci Corp is to revolutionize drug discovery and development by offering a fully-integrated end-to-end platform known as the Absci? Proteomic Engineering Platform. This proprietary technology combines artificial intelligence, machine learning, and high-throughput robotics to streamline and accelerate the process of creating new protein-based therapeutics.

Absci Corp*s platform enables the rapid identification and optimization of proteins that have desired properties for therapeutic uses. It allows researchers to generate vast libraries of diverse protein variants and then screen them for specific functionalities, such as affinity for a target molecule or increased stability. This approach aims to significantly reduce the time and cost associated with traditional drug development methods.

One of the key advantages of Absci Corp*s technology is its integration of E. coli as a host organism for protein production. E. coli is a well-studied and easily manipulated microorganism that can efficiently produce complex proteins. Absci Corp has developed proprietary strains of E. coli that are capable of expressing diverse proteins, including those that are traditionally difficult to produce in other systems. This enables the company to rapidly scale up protein production for preclinical and clinical trials.

Absci Corp also offers protein engineering services to its clients by leveraging its technology platform. These services include protein optimization, affinity maturation, protein stability enhancement, and deimmunization. By combining their platform with their expertise in protein engineering, Absci Corp can assist researchers and pharmaceutical companies in advancing their drug development programs.

Furthermore, Absci Corp has entered into partnerships with several major pharmaceutical and biotechnology companies. These collaborations aim to jointly discover and develop novel therapeutic candidates using Absci Corp*s technology. The company*s partners benefit from access to Absci Corp*s proprietary platform and its expertise, while Absci Corp receives financial support and the opportunity to expand its capabilities and commercial reach.

In addition to its commercial applications, Absci Corp is also actively engaged in advancing scientific research. Its team of scientists regularly publishes their findings in top-tier scientific journals and presents at conferences worldwide. This helps to establish Absci Corp as a thought leader in the field of protein engineering and enhances its reputation as a leading biotechnology company.

Overall, Absci Corp is a cutting-edge biotechnology company that is poised to revolutionize the drug discovery and development process. With its innovative technology platform, extensive expertise in protein engineering, and collaborations with industry partners, Absci Corp is well-positioned to make significant contributions to the field of therapeutics.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com